Alex Nemiroff

General Counsel @ Praxis Precision Medicines arrow icon

About Alex Nemiroff

Alex Nemiroff is a seasoned legal professional and entrepreneur, currently serving as General Counsel and co-founder and CEO of RogCon, Inc. and RogCon U.R., Inc.

Known information

Alex Nemiroff is a distinguished legal professional with a robust background in both the legal and business sectors. He began his career in law as a clerk for the Honorable Paul C. Huck at the United States District Court for the Southern District of Florida, gaining valuable judicial experience. Following his clerkship, Nemiroff worked in commercial and securities litigation at Greenberg Traurig LLP, where he honed his skills in complex legal disputes. Transitioning from law practice to corporate leadership, he co-founded RogCon, Inc. and RogCon U.R., Inc. in November 2015 and has been serving as CEO since. His educational background includes a Bachelor of Business Administration from the University of Michigan’s Ross School of Business and a Juris Doctor from Northwestern University School of Law. In January 2020, Nemiroff took on the role of Vice President of Legal, a position he held until June 2020, before stepping into his current role as General Counsel.

About Praxis Precision Medicines

Praxis Precision Medicines is a biotechnology company based in Boston, Massachusetts, specializing in developing precision therapies for central nervous system disorders using human genetics and translational tools.

report flag Report inaccurate information

People similar to Alex Nemiroff

Marcio Souza

President & Chief Executive Officer @ Praxis Precision Medicines

Marcio Souza is the President & CEO of PTC Therapeutics, with a background in pharmacy and business, and experience across several biopharmaceutical companies.

Tim Kelly

Chief Financial Officer @ Praxis Precision Medicines

Tim Kelly is a finance executive who served as the Chief Financial Officer at Foundation Medicine from January 2019 to April 2021 and has over 15 years of experience in various finance roles at the Roche Group.

Megan Sniecinski is an experienced business executive with a background in pharmaceuticals, having served as Chief Business Officer at BioCryst Pharmaceuticals and held senior leadership roles at PTC Therapeutics.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free